Roles
- Associate Professor of Clinical Medicine
-
Biography
Dr. Munoz Mendoza received his medical degree from the Universidad Nacional Mayor de San Marcos in Lima, Peru. He completed internal medicine residency at Albert Einstein Medical Center in Philadelphia, and fellowship in nephrology at Stanford University in Palo Alto, California. After finishing fellowship, he joined the faculty at the University of Miami, Katz Family Division of Nephrology and Hypertension in 2011.
Dr. Munoz Mendoza is currently an Associate Professor of Clinical Medicine. He is the medical director of DaVita Miami Campus our main outpatient dialysis unit and has a research interest in the relationships between the non-neoplastic histopathological features and kidney function in patients undergoing nephrectomy and cardiovascular disease in patients with chronic kidney disease. -
Education & Training
Education
Post Graduate Training
-
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 2 clinical trials.
-
This is a three-year research study for people with primary membranous nephropathy (Primary MN). The purpose of the studywill test if combining belimumab and rituximab is more effective in treating Primary MN vs. rituximab alone. The study may require up to 19 clinic visits over the three years of the study. Study participants will have procedures that are not part of a routine doctor’s visit. These include completing questionnaires about your personal wellbeing and suicide risks, and extra blood and urine will be collected.
- Principal Investigator: Jair Munoz Mendoza
- Study Phase: TBD
- Enrollment Status: Open
-
A Phase Ib/IIa, Open-Label, Multicenter Clinical Trial to Assess Safety and Efficacy of the Human Anti-CD38 Antibody MOR202 in Anti-PLA2R Antibody Positive Membranous Nephropathy (aMN)
- Principal Investigator: Jair Munoz Mendoza
- Study Phase: Phase 1/Phase 2
- Enrollment Status: Closed